Universität zu Köln

Dietlein, Markus and Drzezga, Alexander (2016). Ablative Radioiodine Therapy at low and intermediate Risk of Relapse High Survival Rate in Thyroid Carcinoma. Nuklearmedizin, 55 (3). S. 71 - 77. STUTTGART: GEORG THIEME VERLAG KG. ISSN 2567-6407

Full text not available from this repository.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Dietlein, Markus UNSPECIFIED UNSPECIFIED UNSPECIFIED Drzezga, Alexander UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-293196
DOI:	10.3413/Nukmed-0792-16-01
Journal or Publication Title:	Nuklearmedizin
Volume:	55
Number:	3
Page Range:	S. 71 - 77
Date:	2016
Publisher:	GEORG THIEME VERLAG KG
Place of Publication:	STUTTGART
ISSN:	2567-6407
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language RADIOACTIVE IODINE TREATMENT; 2ND PRIMARY MALIGNANCIES; POSTOPERATIVE ABLATION; SERUM THYROGLOBULIN; REMNANT ABLATION; CANCER; I-131; METAANALYSIS; GUIDELINES; LEUKEMIA Multiple languages Radiology, Nuclear Medicine & Medical Imaging Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/29319